ALKS — Alkermes plc.
Materials · Pharmaceutical Preparations · Nasdaq
1Insiders filing
3Transactions
+$123kReported buys
−$423kReported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 3 | $546k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-09-01 | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer 10b5-1 | M routine | 5,000 | $24.59 | +$123k | |
| 2026-09-01 | 2026-09-01 | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer 10b5-1 | S | 9,000 | $46.99 | −$423k | |
| 2026-09-01 | 2026-09-01 | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer 10b5-1 | M routine | 5,000 | — | — |
No transactions match these filters.